| SC 13G/A | 2021-01-29 | BlackRock Inc. | Intellia Therapeutics, Inc. | 5,052,845 | 8.6% | EDGAR |
| SC 13D/A | 2021-01-22 | Novartis Institutes for BioMedical Research, Inc. | Intellia Therapeutics, Inc. | 2,176,148 | 3.7% | EDGAR |
| SC 13G/A | 2020-12-09 | Sumitomo Mitsui Trust Holdings, Inc. | Intellia Therapeutics, Inc. | 5,423,218 | 9.2% | EDGAR |
| SC 13G/A | 2020-12-08 | Nikko Asset Management Americas, Inc. | Intellia Therapeutics, Inc. | 5,423,218 | 9.2% | EDGAR |
| SC 13D/A | 2020-08-20 | Novartis Institutes for BioMedical Research, Inc. | Intellia Therapeutics, Inc. | 4,352,295 | 7.4% | EDGAR |
| SC 13D/A | 2020-03-30 | Novartis Institutes for BioMedical Research, Inc. | Intellia Therapeutics, Inc. | 4,352,295 | 8.6% | EDGAR |
| SC 13G/A | 2020-02-14 | ARK Investment Management LLC | Intellia Therapeutics, Inc. | 8,741,432 | 17.9% | EDGAR |
| SC 13G/A | 2020-02-13 | STATE STREET CORP | Intellia Therapeutics, Inc. | - | 3.5% | EDGAR |
| SC 13G/A | 2020-02-12 | Sumitomo Mitsui Trust Holdings, Inc. | Intellia Therapeutics, Inc. | 7,178,520 | 14.7% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | Intellia Therapeutics, Inc. | 3,524,199 | 7.2% | EDGAR |
| SC 13G/A | 2020-02-12 | Nikko Asset Management Americas, Inc. | Intellia Therapeutics, Inc. | 7,178,520 | 14.7% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | Intellia Therapeutics, Inc. | 3,645,230 | 7.5% | EDGAR |
| SC 13G/A | 2019-09-10 | FMR LLC | Intellia Therapeutics, Inc. | 158,606 | 0.3% | EDGAR |
| SC 13G/A | 2019-08-08 | Sumitomo Mitsui Trust Holdings, Inc. | Intellia Therapeutics, Inc. | 6,442,885 | 14.1% | EDGAR |
| SC 13G/A | 2019-08-06 | Nikko Asset Management Americas, Inc. | Intellia Therapeutics, Inc. | 6,442,885 | 14.1% | EDGAR |
| SC 13G | 2019-07-09 | Nikko Asset Management Americas, Inc. | Intellia Therapeutics, Inc. | 5,161,098 | 11.3% | EDGAR |
| SC 13G | 2019-07-09 | Sumitomo Mitsui Trust Holdings, Inc. | Intellia Therapeutics, Inc. | 5,161,098 | 11.3% | EDGAR |
| SC 13G/A | 2019-03-25 | Caribou Biosciences, Inc. | Intellia Therapeutics, Inc. | 1,807,841 | 4.0% | EDGAR |
| SC 13G | 2019-02-14 | ARK Investment Management LLC | Intellia Therapeutics, Inc. | 6,801,952 | 15.7% | EDGAR |
| SC 13G/A | 2019-02-13 | FMR LLC | Intellia Therapeutics, Inc. | 2,414,931 | 5.6% | EDGAR |